Banner

Stem Cell Therapy Global Market Report 2023 – By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), By Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, Other Applications), By EndUser (Hospitals, Clinics) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : January 2023 | SKU CODE : h1133 | Delivery Time: 2-3 business days | Format :


Stem cell therapy refers to a form of regenerative medicine that uses stem cells or their byproducts to stimulate the body's natural repair process in damaged, malfunctioning, or wounded tissue. It is the next step in the transplantation of organs, replacing donor organs—which are scarce—with cells.

The main types of stem cell therapy are allogeneic stem cell therapy and autologous stem cell therapy. Allogeneic stem cell transplantation involves transferring stem cells from a healthy person (the donor) to the patient's body after high-intensity chemotherapy or radiation. The various sources of the cells include adult stem cells; induced pluripotent stem cells, and embryonic stem cells that are used for the treatment of musculoskeletal disorders; wounds and injuries; cancer; autoimmune disorders, and others. The therapies are used by hospitals and clinics.

The stem cell therapy market research report is one of a series of new reports from The Business Research Company that provides stem cell therapy market statistics, including stem cell therapy industry global market size, regional shares, competitors with a stem cell therapy market share, detailed stem cell therapy market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell therapy industry. This stem cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The global stem cell therapy market size will grow from $5.14 billion in 2022 to $6.45 billion in 2023 at a compound annual growth rate (CAGR) of 25.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global stem cell therapy market size is expected to grow to $11.88 billion in 2027 at a CAGR of 16.5%.

The rising prevalence of chronic diseases contributed to the growth of the stem cell therapy market. Long working hours, limited physical activity, and unhealthy eating and drinking habits contribute to the prevalence of chronic diseases among people, thus driving the need for stem cell therapy. According to a United Nations article, by 2030, the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic diseases is expected to reach about 60%. The rising prevalence of chronic diseases is expected to drive the stem cell therapy market.

The high cost of stem cell therapy is expected to limit the growth of the stem cell therapy market. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective therapies for chronic diseases has impacted the health conditions of the population and has led to a low average life expectancy. According to the DVCSTEM, the average cost of stem cell therapy in the USA is between $20,000 to $25,000, in Mexico, it is $33,000, in Central America, it is $30,000, and in Asia, it is $50,000, thus restraining the growth of the market.

The companies in the stem cell therapy market are increasingly investing in strategic partnerships. A strategic partnership is a mutually beneficial agreement between two companies that do not compete directly with each other. For instance, in June 2020, Shanghai Cell Therapy Group (SHCell) has recently begun a six-year research collaboration with Professor Qi-Long Ying of the University of Southern California (USC). The Ying laboratory hopes to develop conditions for long-term ex vivo expansion of mouse and human hematopoietic stem and progenitor cells through the project, which is supported by $3.6 million from the Baize Plan Fund.

In July 2020, Boehringer Ingelheim, a Germany-based pharmaceutical company, acquired Global Stem Cell Technology (GST) for an undisclosed amount. The acquisition completely supports Boehringer Ingelheim's Animal Health strategy, which aims to improve its portfolio capabilities to spur innovation and growth. The purchase comes after a two-year, fruitful relationship that saw the introduction of the first-ever registered stem cell-based veterinary treatment to the European market. GST is a Belgian biotech company that develops and produces state-of-the art stem cell products for horses and pets.

Major players in the stem cell therapy market are Anterogen, JCR Pharmaceuticals, Medipost, Osiris Therapeutics, Pharmicell, Astellas Pharma, Cellectis, Celyad, Novadip Biosciences, Gamida Cell, Capricor Therapeutics, Cellular Dynamics, CESCA Therapeutics, DiscGenics, OxStem, Mesoblast, ReNeuron Group, Takeda Pharmaceuticals, Magellan, Kolon TissueGene, Stemedica Cell Technologies, Holostem Terapie Avanzate S.r.l., NuVasive, RTI Surgical and AlloSource.

North America was the largest region in the stem cell therapy market in 2022. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the global stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the stem cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The stem cell therapy market includes revenues earned by entities by hematopoietic stem cells, skin stem cells, neural stem cells, and mesenchymal stem cells. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global stem cell therapy market is segmented -

1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy

2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells

3) By Application: Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, Other Applications

4) By End-User: Hospitals, Clinics

    Table Of Contents

    1. Executive Summary

    2. Stem Cell Therapy Market Characteristics

    3. Stem Cell Therapy Market Trends And Strategies

    4. Stem Cell Therapy Market – Macro Economic Scenario

    4.1 COVID-19 Impact On Stem Cell Therapy Market

    4.2 Ukraine-Russia War Impact On Stem Cell Therapy Market

    4.3 Impact Of High Inflation On Stem Cell Therapy Market

    5. Stem Cell Therapy Market Size And Growth

    5.1. Global Stem Cell Therapy Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Stem Cell Therapy Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Stem Cell Therapy Market Segmentation

    6.1. Global Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Allogeneic Stem Cell Therapy

    Autologous Stem Cell Therapy

    6.2. Global Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Adult Stem Cells

    Induced Pluripotent Stem Cells

    Embryonic Stem Cells

    6.3. Global Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Musculoskeletal Disorders

    Wounds and Injuries

    Cancer

    Autoimmune Disorders

    Other Applications

    6.4. Global Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospitals

    7. Stem Cell Therapy Market Regional And Country Analysis

    7.1. Global Stem Cell Therapy Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Stem Cell Therapy Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Stem Cell Therapy Market

    8.1. Asia-Pacific Stem Cell Therapy Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Stem Cell Therapy Market

    9.1. China Stem Cell Therapy Market Overview

    9.2. China Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Stem Cell Therapy Market

    10.1. India Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Stem Cell Therapy Market

    11.1. Japan Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Stem Cell Therapy Market

    12.1. Australia Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Stem Cell Therapy Market

    13.1. Indonesia Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Stem Cell Therapy Market

    14.1. South Korea Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Stem Cell Therapy Market

    15.1. Western Europe Stem Cell Therapy Market Overview

    15.2. Western Europe Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Stem Cell Therapy Market

    16.1. UK Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Stem Cell Therapy Market

    17.1. Germany Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Stem Cell Therapy Market

    18.4. France Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Stem Cell Therapy Market

    19.1. Eastern Europe Stem Cell Therapy Market Overview

    19.2. Eastern Europe Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Stem Cell Therapy Market

    20.1. Russia Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Stem Cell Therapy Market

    21.1. North America Stem Cell Therapy Market Overview

    21.2. North America Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Stem Cell Therapy Market

    22.1. USA Stem Cell Therapy Market Overview

    22.2. USA Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Stem Cell Therapy Market

    23.1. South America Stem Cell Therapy Market Overview

    23.2. South America Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Stem Cell Therapy Market

    24.1. Brazil Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Stem Cell Therapy Market

    25.1. Middle East Stem Cell Therapy Market Overview

    25.2. Middle East Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Stem Cell Therapy Market

    26.1. Africa Stem Cell Therapy Market Overview

    26.2. Africa Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Stem Cell Therapy Market Competitive Landscape And Company Profiles

    27.1. Stem Cell Therapy Market Competitive Landscape

    27.2. Stem Cell Therapy Market Company Profiles

    27.2.1. Anterogen

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. JCR Pharmaceuticals

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Medipost

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Osiris Therapeutics

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Pharmicell

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Stem Cell Therapy Pipeline Analysis

    29. Key Mergers And Acquisitions In The Stem Cell Therapy Market

    30. Stem Cell Therapy Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Historic And Forecast Inflation Rates

    31.4. Research Inquiries

    31.5. The Business Research Company

    31.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Stem Cell Therapy Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Global Stem Cell Therapy Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: Asia-Pacific, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: China, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: India, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Japan, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Australia, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Indonesia, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: South Korea, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Western Europe, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: UK, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: Germany, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: France, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Eastern Europe, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: Russia, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: North America, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: USA, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: South America, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Brazil, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Middle East, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Africa, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 47: Anterogen Financial Performance
  • Table 48: JCR Pharmaceuticals Financial Performance
  • Table 49: Medipost Financial Performance
  • Table 50: Osiris Therapeutics Financial Performance
  • Table 51: Pharmicell Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Stem Cell Therapy Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Global Stem Cell Therapy Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: Asia-Pacific, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: China, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: India, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Japan, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Australia, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Indonesia, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: South Korea, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Western Europe, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: UK, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: Germany, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: France, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Eastern Europe, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: Russia, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: North America, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: USA, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: South America, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Brazil, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Middle East, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Africa, Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 47: Anterogen Financial Performance
  • Figure 48: JCR Pharmaceuticals Financial Performance
  • Figure 49: Medipost Financial Performance
  • Figure 50: Osiris Therapeutics Financial Performance
  • Figure 51: Pharmicell Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report